Cancer related to blood cells is called as Leukemia. Under Leukemia condition, bone marrow produces abnormal cancerous blood cells that crowd out the normal and healthy blood cells. Leukemia is of different types based which blood cell type has become cancerous. White blood cells are more to prone to become cancerous than RBCs and platelets. Leukemia can be acute or chronic and Lymphocytic or Myelogenous. It occurs most commonly in adults above 55 years and children younger than 15 years. The treatment methods used depend on the blood cell affected and whether the leukemia is acute or chronic or Lymphocytic or Myelogenous. Chemotherapy is frequently used to treat leukemia.
Data analysis evaluated 12-month survival (12-ms) in 3 987 children diagnosed between 2000 and 2008 with lymphoid leukemia (LL) and myeloid leukemia (ML) and registered in Argentina's population-based oncopediatric registry resulted overall 12-ms for LL and ML cases was 83.7% and 59.9% respectively. RP detected major gaps in 12-ms. Among 1-10-year-old LL patients from poorer provinces, 12-ms for those who did and did not migrate was 87.0% and 78.2% respectively. Survival of ML patients < 2 years old from provinces with a low/medium socioeconomic index was 38.9% compared to 62.1% for those in the same age group from richer provinces. For 2-14-year-old ML patients living in poor provinces, patient migration was associated with a 30% increase in 12-ms.